ArticleCell reports. Medicine2023

A broadly reactive antibody targeting the N-terminal domain of SARS-CoV-2 spike confers Fc-mediated protection.

Lucas J Adams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.